Interventions for alcohol-related brain damage (ARBD): Do specific approaches restrict the evolution of comprehensive patient care?

References

• Arbias. (2011). Looking forward: Information & specialised advice on alcohol-related brain impairment. Australia: Arbias
   Google Scholar
• Bardenhagen, F.J., Oscar-Berman, M., & Bowden, S.C. (2007). Rule knowledge aids performance on spatial and object alternation tasks by alcoholic patients with and without Korsakoff’s amnesia. Neuropsychiatric Disease and Treatment, 3, 907–918
   PubMedGoogle Scholar
• Blansjaar, B.A., Takens, H., & Zwinderman, A.H. (1992). The course of alcohol amnestic disorder: A three-year follow-up study of clinical signs and social disabilities. Acta Psychiatrica Scandinavica, 86, 240–246
   PubMed Web of Science ®Google Scholar
• Carota, A., & Schneider, A. (2005). Dramatic recovery from prolonged WernickeKorsakoff disease. European Neurology, 53, 45–46
   PubMed Web of Science ®Google Scholar
• Cermak, L.S. (1975). Imagery as an aid to retrieval for Korsakoff patients. Cortex, 11, 163–169
   PubMedGoogle Scholar
• Cermak, L.S. (1980). Improving retention in alcoholic Korsakoff patients. Journal of Studies on Alcohol, 41, 159–169
   PubMed Web of Science ®Google Scholar
• Cochrane, M., Cochrane, A., Jauhar, P., & Ashton, E. (2005). Acetylcholinesterase inhibitors for the treatment of Wernicke–Korsakoff Syndrome – Three further cases show response to donepezil. Alcohol and Alcoholism, 40, 151–154
   PubMed Web of Science ®Google Scholar
• Cook, C.C.H. (2000). Prevention and treatment of Wernicke–Korsakoff syndrome. Alcohol and Alcoholism, 35, 19–20
   Google Scholar
• Cook, C.C.H., & Thomson, A.D. (1997). B-complex vitamins in the prophylaxis and treatment of Wernicke–Korsakoff syndrome. British Journal of Hospital Medicine, 57, 461–465
   PubMed Web of Science ®Google Scholar
• Cox, S., Anderson, I., & McCabe, L. (2004). A fuller life: Report of the expert group on alcohol related brain damage. Stirling: University of Stirling, Dementia Services Development Centre
   Google Scholar
• Davies, A.D.M., & Binks, M.G. (1983). Supporting the residual memory of a Korsakoff patient. Behavioural Psychotherapy, 11, 62–74
   Web of Science ®Google Scholar
• Day, E., Bentham, P.W., Callaghan, R., Kuruvilla, T., & George, S. (2013). Thiamine for prevention and treatment of Wernicke–Korsakoff Syndrome in people who abuse alcohol (Review). Cochrane Database of Systematic Reviews, 7, 1–20
   Google Scholar
• Diamant, J.J., & Huijsman, A.M. (1982). Neuropsychological rehabilitation of psychiatric patients with brain dysfunction: A case study. Clinical Neuropsychology, 5, 1–4
   Google Scholar
• Ferrin, J.M. (1993). Drug efficacy in the treatment of Wernicke and Korsakoff syndromes: A review for rehabilitation professionals. Journal of Applied Rehabilitation Counselling, 25, 32–35
   Google Scholar
• Goldstein, G., & Malec, E.A. (1989). Memory training for severely amnesic patients. Neuropsychology, 3, 9–16
   Google Scholar
• Gupta, S., & Warner, J. (2008). Alcohol-related dementia: A 21st-century silent epidemic? The British Journal of Psychiatry, 193, 351–353
   Google Scholar
• Heinrichs, R.W., Levitt, H., Arthurs, A., Gallardo, C., Hirscheimer, K., MacNeil, M. … Richards, K. (1992). Learning and retention of a daily activity schedule in a patient with alcohol Korsakoff’s syndrome. Neuropsychological Rehabilitation, 2, 43–58
   Google Scholar
• Hemmingsen, R., Kramp, P., & Rafaelsen, O.J. (1983). Organic cerebral reactions in alcoholism: Psychobiological aspects of treatment. Substance and Alcohol Actions/Misuse, 4, 225–234
   PubMedGoogle Scholar
• Hochhalter, A.K., & Joseph, B. (2001). Differential outcomes training facilitates memory in people with Korsakoff and Prader-Willi syndromes. Integrative Physiological and Behavioural Science, 36, 196–204
   PubMed Web of Science ®Google Scholar
• Hochhalter, A.K., Sweeney, W.A., Bakke, B.L., Holub, R.J., & Overmier, B. (2001). Improving face recognition in alcohol dementia. Clinical Gerontologist, 22, 3–18
   Google Scholar
• Iga, J.I., Araki, M., Ishimoto, Y., & Ohmori, T. (2001). A case of Korsakoff’s syndrome improved by high doses of donepezil. Alcohol and Alcoholism, 36, 553–555
   PubMed Web of Science ®Google Scholar
• Irvine, C., & Mawhinney, S. (2008). Functioning of individuals with Korsakoff’s syndrome: A pilot study of supported group living in Northern Ireland. Mental Health Review Journal, 13, 16–23
   Google Scholar
• Isenberg, G.E., Kutner, H.E., & Nicolson, S.E. (2012). Wernicke-Korsakoff syndrome: Under-recognized and under-treated. Psychosomatics: Journal of Consultation Liason Psychiatry, 53, 507–516
   PubMedGoogle Scholar
• Jennekins-Schinkel, A., Wintzen, A.R., & Lanser, J.B.K. (1985). A clinical trial with desglyncinamide arginine vasopressin for the treatment of memory disorders in man. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 9, 273–284
   PubMed Web of Science ®Google Scholar
• Kashima, H., Kato, M., Yoshimasu, H., & Muramatsu, T. (1998). Current trends in cognitive rehabilitation for memory disorders. Keio Journal of Medicine, 48, 79–86
   Google Scholar
• Kessels, R.P.C. (2007). Route learning in amnesia: A comparison of trial-and-error and errorless learning in patients with the Korsakoff syndrome. Clinical Rehabilitation, 21, 905–911
   PubMed Web of Science ®Google Scholar
• Komatsu, S., Mimura, M., Kato, M., Wakamatsu, N., & Kashima, H. (2000). Errorless and effortful processes involved in the learning of face-name associations by patients with alcoholic Korsakoff’s syndrome. Neuropsychological Rehabilitation, 10, 113–132
   Web of Science ®Google Scholar
• Kopelman, M.D., Thomson, A.D., Guerrini, I., & Marshall, E.J. (2009). The Korsakoff syndrome: Clinical aspects, psychology and treatment. Alcohol and Alcoholism, 44, 148–154
   PubMed Web of Science ®Google Scholar
• Laczi, F., Van Ree, J.M., Balogh, L., Szasz, A., Jardanhazy, T., Wagner, A. … De Wied, D. (1983). Lack of effect of desglycinamide-arginine-vasopressin (DGAVP) on memory in patients with Korsakoff’s syndrome. Acta Endocrinologia, 104, 177–182
   PubMedGoogle Scholar
• Langlais, P.J., Mair, R.G., Whalen, P.J., McCourt, W., & McEntee, W.J. (1988). Memory effect of DL-threo-3,4-dihydroxyphenylserine (DOPS) in human Korsakoff’s disease. Psychopharmacology, 95, 250–254
   PubMed Web of Science ®Google Scholar
• Leigh, D., McBurney, A., & McIlwain, H. (1981). Erythrocyte transketolase activity in the Wernicke–Korsakoff syndrome. British Journal of Psychiatry, 139, 153–159
   PubMed Web of Science ®Google Scholar
• Lennane, K.J. (1986). Management of moderate to severe alcohol-related brain damage (Korsakoff’s syndrome). The Medical Journal of Australia, 145, 136–143
   PubMed Web of Science ®Google Scholar
• Luykx, H.J., Dorresteijn, L.D.A., Haffmas, P.M.J., Bonebakker, A., Kerkmeer, M., & Hendriks, V.M. (2008). Rivastigmine in Wernicke-Korsakoff’s Syndrome: Five patients with rivastigmine showed no more improvement than five patients without rivastigmine. Alcohol and Alcoholism, 43, 70–72
   PubMed Web of Science ®Google Scholar
• MacRae, S., & Cox, S. (2003). Meeting the needs of people with alcohol-related brain damage: A literature review on the existing and recommended service provision and models of care. Stirling: University of Stirling
   Google Scholar
• Mantzoukas, S. (2008). A review of evidence-based practice, nursing research and reflection: Levelling the hierarchy. Journal of Clinical Nursing, 17, 214–223
   PubMed Web of Science ®Google Scholar
• Martin, P.R., Adinoff, B., Eckhardt, M.J., Stapleton, J.M., Bone, G.A.H., Rubinow, M.D. … Linnoila, M. (1989). Effective pharmacotherapy of alcoholic amnestic disorder with fluvoxamine. Archives of General Psychiatry, 46, 617–621
   PubMed Web of Science ®Google Scholar
• McIntosh, C., Kippen, V., Hutcheson, F., & McIntosh, A. (2005). Parenteral thiamine use in the prevention and treatment of Wernicke-Korsakoff syndrome. Psychiatric Bulletin, 29, 94–97
   Google Scholar
• Mental Welfare Commission for Scotland. (2010). Missed opportunities: Findings from our visits to people with acquired brain injury and alcohol related brain damage. Edinburgh: Mental Welfare Commission for Scotland
   Google Scholar
• Mimura, M., Komatsu, S., Kato, M., Yoshimasu, H., Wakamatsu, N., & Kashima, H. (1998). Memory for subject performed tasks in patients with Korsakoff syndrome. Cortex, 34, 297–303
   PubMed Web of Science ®Google Scholar
• Mimura, M., Komatsu, S., Kato, M., Yoshimasu, H., Moriyama, Y., & Kashima, H. (2005). Further evidence for a comparable memory advantage of self-performed tasks in Korsakoff’s syndrome and nonamnesic control subjects. Journal of the International Neuropsychological Society, 11, 545–553
   PubMed Web of Science ®Google Scholar
• Moher, D., Liberati, A., Tetzlaff, J., & Altman, D.G. (2009). Preferred reporting for systematic reviews and meta-analyses: The PRISMA statement. Journal of Clinical Epidemiology, 62, 1006–1012
   Google Scholar
• Monteiro, M.F.A., Bolognani, S.A.P., Rivero, T.S., & Bueno, O.F.A. (2011). Neuropsychological intervention in a case of Korsakoff’s amnesia. Brain Impairment, 12, 231–238
   Web of Science ®Google Scholar
• Morgan, J., McSharry, K., & Sireling, L. (1990). Comparison of a system of staff prompting with a programmable electronic diary in a patient with Korsakoff’s syndrome. International Journal of Social Psychiatry, 36, 225–229
   PubMedGoogle Scholar
• Morrison, F., & Pestell, S. (2010). The application of cognitive behaviour therapy to individuals with co-morbid depression and alcohol-related brain damage. Clinical Psychology Forum, 206, 13–18
   Google Scholar
• National Institute for Health and Clinical Excellence. (2011). Alcohol-use disorders: Diagnosis, assessment and management of harmful drinking and alcohol dependence. Manchester: National Institute for Health and Clinical Excellence
   Google Scholar
• O’Carroll, R.E., Moffoot, A.R.R., Ebmeier, K.P., & Goodwin, G.M. (1994). Effects of fluvoxamine treatment on cognitive functioning in the alcoholic Korsakoff syndrome. Psychopharmacology, 116, 85–88
   PubMed Web of Science ®Google Scholar
• O’Carroll, R.E., Moffoot, A.R.R., Ebmeier, K.P., Murray, C., & Goodwin, G.M. (1993). Korsakoff’s syndrome, cognition and clonidine. Psychological Medicine, 23, 341–347
   PubMed Web of Science ®Google Scholar
• O’Donnell, V.M., Pitts, W.M., & Fann, W.E. (1986). Noradrenergic and cholinergic agents in Korsakoff’s syndrome. Clinical Neuropharmacology, 9, 65–70
   PubMed Web of Science ®Google Scholar
• Reuster, T., Buechler, J., Winiecki, P., & Oehler, J. (2003). Influence of reboxetine on salivary MHPG concentration and cognitive symptoms among patients with alcohol-related Korsakoff’s syndrome. Nueropharmacology, 28, 974–978
   Google Scholar
• Rustembegovic, A., Kundurovic, Z., Sapcanin, A., & Sofic, E. (2003). A placebo-controlled study of Memantine (Ebixa) in dementia of Wernicke-Korsakoff syndrome. Medicinski Arhiv, 57, 149–150
   PubMedGoogle Scholar
• Scottish Intercollegiate Guidance Network. (2003). The management of harmful drinking and alcohol dependence in primary care. Edinburgh: Scottish Intercollegiate Guidance Network
   Google Scholar
• Smith, I., & Hillman, A. (1999). Management of alcohol Korsakoff syndrome. Advances in Psychiatric Treatment, 5, 271–278
   Google Scholar
• Sum, S.S.M., & Brody, R. (2012). The link between thiamine supplementation and treatment of Wernicke–Korsakoff syndrome in patients with alcoholism. Topics in Clinical Nutrition, 27, 334–338
   Google Scholar
• Svanberg, J., & Evans, J.J. (2013). Neuropsychological rehabilitation in alcohol-related brain damage: A systematic review. Alcohol and Alcoholism, 4, 704–711
   Google Scholar
• Thomson, A.D., Guerrini, I., & Marshall, E.J. (2012). The evolution and treatment of Korsakoff’s syndrome: Out of sight, out of mind? Neuropsychology Review, 22, 81–92
   PubMed Web of Science ®Google Scholar
• Thomson, A.D. Marshall, J.E., & Bell, D. (2012). Time to act on the inadequate management of Wernicke’s encephalopathy in the UK. Alcohol and Alcoholism, 48, 4–8
   PubMed Web of Science ®Google Scholar
• Van Damme, I., & d’Ydewalle, G. (2008). Elaborative processing in the Korsakoff syndrome: Context versus habit. Brain and Cognition, 67, 212–224
   PubMed Web of Science ®Google Scholar
• Williams, C., & Martinez, R. (2008). Increasing access to CBT: Stepped care and CBT self-help models in practice. Behavioural and Cognitive Psychotherapy, 36, 675–683
   Web of Science ®Google Scholar
• Wilson, B.A., Baddeley, A., Evans, J., & Shiel, A. (1994). Errorless learning in the rehabilitation of memory impaired people. Neuropsychological Rehabilitation: An International Journal, 4, 307–326
   Web of Science ®Google Scholar
• Wilson, K. (2011). Alcohol-related brain damage: A 21st Century management conundrum. The British Journal of Psychiatry, 199, 176–177
   PubMed Web of Science ®Google Scholar
• Wilson, K., Halsey, A., Macpherson, H., Billington, J., Hill, S., Johnson, G. … Abbott, P. (2012). The psycho-social rehabilitation of patients with alcohol-related brain damage in the community. Alcohol and Alcoholism, 47, 304–311
   PubMed Web of Science ®Google Scholar
• Woods, R.T. (1982). Specificity of learning in reality-orientation sessions: A single-case study. Behaviour Research and Therapy, 21, 173–175
   Web of Science ®Google Scholar
• Yudofsky, S.C., Stevens, L., Silver, J., Barsa, J., & Williams, D. (1984). Propranolol in the treatment of rage and violent behavior associated With Korsakoff’s psychosis. American Journal of Psychiatry, 141, 114–115
   PubMed Web of Science ®Google Scholar
• Zahr, N.M., Kaufman, K.L., & Harper, C.G. (2011). Clinical and pathological features of alcohol-related brain damage. Nature Reviews Neurology, 7, 284–294
   PubMed Web of Science ®Google Scholar